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                                          INTRODUCTION 
 
                                  WHO defines dementia as a “syndrome due to 
disease of brain, usually of a chronic progressive nature, in which 
there is disturbance of multiple cortical functions, calculations, 
learning capacity, language and judgement. Consciousness is not 
clouded. Impairments in cognitive functions are commonly 
accompanied, and occasionally preceded by emotional control, 
social behaviour and motivation”. 
 
                                Dementia is defined as “ the development of 
multiple cognitive deficits that include memory impairment and at 
least one of the following: aphasia, apraxia, agnosia, or a disturbance 
in executive functioning, where executive functioning involves 
selection of key information and behaviours for problem solving and 
the inhibition of inappropriate responses”(DSM IV, TR). 
 
                                The most common causes of dementia in 
individuals older than 65 years of age are: Alzheimer’s disease, 
vascular dementia and mixed vascular and Alzheimer’ s disease, of 
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which Alzheimer’s disease accounts for approximately 60% of all 
dementias. The prevalence of Alzheimer’s disease is 3 to 5% of 
people older than 65 years of age and as much as 50% of people 
older than 85 years of age. The female to male ratio is approximately 
2:1. 
 
                               Patients with Alzheimer’s disease display 
characteristic cognitive and non-cognitive symptoms over the course 
of the illness. Neuropsychiatric symptoms may be prominent at 
presentation or emerge later in the course. Almost all patients are 
affected at some point in their disease. 
 
                                   Neuropsychiatric symptoms in 
Alzheimer’s disease have significant consequences. Disorders such 
as depression, anxiety, and psychosis clearly affect the quality of life 
of the patient. Besides being a source of considerable stress, 
caregiver burden and potential injury, such disturbances are 
associated with increased use of psychotropic medications, patient 
and caregiver abuse. Non-cognitive symptoms are associated with an 
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increased risk for institutionalization, which carries with it financial 
consequences for the individual and for society. 
 
                                  Characteristics of Neuropsychiatric symptoms 
in Alzheimer’s disease include the following: 
 
• They may be the sentinel event heralding the onset of 
Alzheimer’s disease. 
• Several types of symptoms may occur simultaneously, 
fluctuate and recur over the course of illness. 
• They tend to become more frequent as the disease progresses. 
• They are associated with rapid cognitive decline and worsen 
function. 
• They may lead to institutionalization. 
• Importantly, these Neuropsychiatric symptoms may improve 
with cholinergic therapy, disease modifying therapy and 
psychotropic agents. 
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                                The Neuropsychiatric symptoms play an 
important role in the diagnosis and management of Alzheimer’s 
disease. Early identification and treatment of these symptoms 
reduces patient’s suffering, caregiver burden and delay 
institutionalization. 
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                                                   REVIEW OF LITERATURE 
 
 
                                     Approximately 5% of community dwelling elderly 
individuals have dementia and the prevalence of dementia will quadruple by 
the year 2050 (Judith et al).  Stevens et al, in his study in 2002 found that 
Alzheimer‘s dementia, vascular dementia, mixed dementia and diffuse Lewy 
body dementia account for the majority of dementia cases 
 
                                     Alzheimer‘s dementia, the most common cause of 
dementia in most countries is a slowly progressive dementia in which memory 
disorder is the usual presenting symptom. The earliest sign of a memory 
problem is usually a defect in the delayed verbal recall. As disease progresses, 
memory impairment is manifested by difficulty in learning new information. 
Language disturbances, difficulty in performing coordinated motor tasks, 
failure to recognize sensory stimuli in the absence of sensory deficits and 
deficits in executive functioning evolve during the course of illness. As the 
disease advances, non-cognitive symptoms become evident. 
                                     
 
                                    The neuropsychological and functional deficits in 
dementia are often accompanied by neuropsychiatric symptoms. Eisdorfer et 
al, described two syndromes that Alzheimer ‘s dementia a cognitive syndrome 
and a behavioural syndrome, which overlap between the courses of the disease. 
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These neuropsychiatric symptoms may be the presenting complaint or may 
emerge in the course of the disease. In 1996, the International Psycho 
geriatric association (IPA) arrived at a consensus on the use of more 
appropriate and descriptive term regarding behavioural symptoms that would 
facilitate communication among researchers and therefore foster further 
development of the Dementia. Behavioural and psychological symptoms of 
Dementia (BPSD), was introduced and defined as “ signs and symptoms 
ofdisturbed perception, thought content, mood or behaviour that frequently 
occur in patients with dementia”. BPSD includes Sub syndromes like 
psychosis, circadian rhythm disturbance, depression, anxiety, agitation and 
other less well defined syndromes (Finkel et al). 
                                      
                                   Most patients with Alzheimer‘s dementia exhibit non-
cognitive symptoms at some point during the course of their illness. Some 
symptoms, such as agitation and psychosis are more likely to result in medical 
evaluation of others. Assessment instruments that probe for behaviours 
occurring with in a defined time period may miss other symptoms, such as 
intermittent physical aggression. These disturbances may adversely affect the 
functional status of patients with Alzheimer‘s dementia resulting in significant 
disability. 
 
FACTORS CONTRIBUTING TO THE ETIOLOGY OF BEHAVIORAL  
 
 7
PROBLEMS IN ALZHEIMER ‘S DEMENTIA 
 
 
                                  Regarding the genesis of noncognitive psychiatric 
symptoms of Alzheimer ‘ s dementia, several factors have been implicated, 
important being the structural involvement, environmental factors, iatrogenic 
causes and somatic illnesses. Farber et al suggested an interaction between 
mechanisms in the brain that regulate psychosis and disease mechanisms 
specific to Alzheimer ‘s dementia. 
 
This disease is also known to affect brainstem nuclei that manufacture the  
 
neurotransmitters that are commonly implicated in psychiatric illness, and  
 
adrenergic and serotoninergic systems as well as cholinergic are involved in  
 
Alzheimer ‘s dementia. This concept is supported by the observation by Levy 
et al, Alzheimer ‘s dementia is often treatable by psychotropic agents that have 
little effect on cognition or the underlying degenerative process of the disease 
In patients with Alzheimer’s disease, degeneration of brainstem nuclei may 
produce a deficit in norepinephrine that relates to alteration in the mood. 
Zubenko and colleagues noted that the brain of patients with dementia and 
major depression had neurochemical disturbances, including decreased levels 
of norepinephrine. Other studies have found that depressed AD patients have 
greater reductions in cell numbers in the substantia nigra when compared with 
non-depressed patients.  
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                               The apolipoprotein E4 allele is the most consistently 
identified genetic risk factor for Alzheimer ‘s dementia. However, this allele 
has not been consistently associated with any of the neuropsychiatric 
manifestations of Alzheimer ‘s dementia. With regard to delusions and 
hallucinations, three studies have found an association between psychosis and 
apolipoprotein E4 allele (Ramachandran et al). Zubenko and colleagues 
examined brain tissue from 27 patients with AD and found that psychosis was 
associated with increased senile plaques in prosubiculum, increased neuro 
fibrillary tangles in middle frontal cortex, the relative preservation of nor 
epinephrine in substantia nigra, and a reduction of serotonin in the 
prosubiculum. In the Cache county study by Steinberg et al, gender, age, 
dementia, apolipoprotein E4 allele, type of dementia and general medical 
health were reported to influence the occurrence of individual neuro 
psychiatric symptoms. 
 
                                          Alan Jacques and Graham in their study reported that 
environmental factors such as large group living, lack of activities, locked 
doors, loneliness, inappropriate noises may contribute to the development of 
behavioural and psychiatric symptoms in dementia. Cohen-Mansfield et al, 
have studied relationship between patients needs, the environment and 
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agitation. Cohen-Mansfield et al have defined agitation as “inappropriate 
verbal, vocal end motor activity that is not judged by an outside observer to 
result directly from the needs or confusion of the agitated individual”. They 
found that a large number of patients with verbal aggression had undiagnosed 
hip fracture and suggested that presence of unmet medical needs is an 
important contributor of all behavioural and psychiatric symptoms in dementia. 
Further more, an evaluation of the correlation between behaviours such as 
verbal aggression and environmental factors shows that the quality of the 
patient’s social environment is inversely proportional to the presence of verbal 
aggression. 
 
 
 
                                  Although the exact etiology of behavioural and 
psychiatric symptoms in dementia remains unknown, evidence suggests that a 
combination of behaviour specific biological and environmental factors may be 
responsible for the onset of symptoms. Understanding the various factors in the 
causation of behavioural and psychiatric symptoms in dementia would help us 
create a new and creative intervention in managing them. 
 
 
 
 
NEED FOR ASSESSMENT OF BEHAVIOURAL SYMPTOMS IN 
DEMENTIA 
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                                         Neuropsychiatric symptoms may be the presenting 
manifestations of dementing disorders, appearing before cognitive alterations 
and heralding the onset of brain disease (Rubin et al). Shaji and colleagues 
reported that these symptoms remain the major source of caregivers distress. 
They remain as an important contributor to the decision of instituitionalise 
Alzheimer’s disease patients (Deutsch et al). Some of these symptoms like 
agitation and aberrant motor behaviour predict severe cognitive decline. As the 
disease progress, the symptomatology changes, requiring re evaluation and 
implementation of new interventions in the course of illness. 
 
 
 
                         Thus neuropsychiatric features in dementia have important  
 
diagnostic, prognostic and management implications. Cynthia et al, found that 
 early detection and assessment of these potentially treatable (non cognitive) 
behavioural and psychiatric symptoms might delay the process of 
institutionalization, caregiver burden and also would decrease the functional 
impairment. Further, behavioural assessment may help differentiating between 
different forms of dementia, further stressing the need for the development of 
new and more sensitive behavioural assessment scales (Engelborghs et al) 
Also, the loss of autonomy of activities of daily living is determined by the 
presence of behavioural symptoms and cognitive decline (Lechowski et al). 
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                                    A number of standardized instruments have been 
developed for the assessment of non-cognitive symptoms in dementia. The 
validated and reliable multi dimensional tools that are most commonly used are 
the Alzheimer’s disease–Non cognitive portion (ADAS-noncog), the 
Neuropsychiatric inventory (NPI) and the Behavioural Pathology In 
Alzheimer’s disease Rating Scale (BEHAVE-AD). The ADAS-non cog covers 
a variety of symptoms like tearfulness, depression, loss of concentration, 
uncooperativeness, pacing, delusions, hallucinations, tremor and appetite 
changes. The NPI evaluates delusions, hallucinations, agitation, anxiety, 
dysphoria, euphoria, irritability, disinhibition, apathy and aberrant motor 
behaviour. The BEHAVE-AD focuses on paranoia, hallucinations, activity 
disturbances, aggressiveness, diurnal rhythm disturbances, anxiety and 
phobias. 
 
 
 
 
SPECTRUM OF BEHAVIOURAL CHANGES IN ALZHEIMER’S 
DEMENTIA AND IT’S RELATION TO COGNITIVE DECLINE 
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                                       Neuropsychiatric disorders have an impact on the 
course of cognitive decline in patients with Alzheimer’s disease.The presence 
of psychosis, agitation and depression have been identified as being possible 
predictors of accelerated intellectual decline. 
 
                                  Patients with Alzheimer’s dementia are commonly 
assumed to experience a linear decline in behavioural functioning that parallels 
cognitive decline. However, the behavioural manifestations may vary as the 
disease progresses. 
 
                                      Cross-sectional studies indicated curvilinear associations 
between dementia severity and certain behavioral problems (forgetful 
behaviors, and motional and impulsive behaviors). Longitudinal analyses by 
McCarty et al, further indicated trends for curvilinear rates of behavioral 
disturbance across time, with some problem areas showing improvement as 
AD progresses through the most severe stages. There exists controversy 
regarding the occurrence of behavioural disturbance in patients with varying 
severity of dementia although it is generally accepted that the prevalence of 
delusions and hallucinations increase as the disease progresses (Burns et al). 
 
                                          In a study done by Mega et al, symptoms like 
agitation, dysphoria, apathy and aberrant motor behaviour had significant 
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correlation with cognitive impairment .The frequency and clinical correlates of 
physically aggressive behaviour in patients with dementia have been assessed 
in several studies. Several other neuropsychiatric symptoms like delusions may 
predispose an individual with dementia to aggression (Morris et al). 
                                            Both major and minor depression is common in 
Alzheimer’s dementia produce considerable mood and nonmood morbidity 
affecting both patients and caregivers (Lykestos et al). Disturbances in mood 
and manifestations of agitation and psychotic symptoms are not closely related 
to one another and show little progressive worsening over time. Rather, they 
tend to be episodic such that increasing severity at one time is usually followed 
by improvement later. Concentration problems are a manifestation of cognitive 
dysfunction rather than behavioral disturbance in Alzheimer’s dementia (Marin 
et al ). 
                                    Ravetz RS in his study found that the first stage of 
Alzheimer's disease commonly is marked by anxiety and depression secondary 
to memory impairment, and delusions. In the second stage, delusions often 
become more bizarre. Impairment of visuospatial memory, improper advances, 
and obscene language begin to replace disinhibited behavior, often to the point 
of violence directed at others. Increasing agitation requires restraints. In the 
third and final stage, screaming, banging, and cursing are common features. 
Verbal and behavioral perseverations are very common. 
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                                   One year longitudinal evaluation of neuropsychiatric 
symptoms in Alzheimer’s disease in the REAL FR study by Benoit et al, 
reported that When compared to non institutionalized patients, the 
institutionalized group was characterized at base line by a lower MMSE score, 
a higher caregiver burden score, and a higher NPI agitation and disinhibition 
scores. 
                             Delusions and hallucinations are among the most common  
noncognitive neuropsychiatric symptoms seen in patients with dementia and 
have been reported to occur in a large proportion of patients with Alzheimer's 
disease. Delusions and hallucinations strongly contribute to early 
institutionalization, reduce patients' well being, and increase the burden of the 
caregiver in managing the patient Furthermore, these disturbances are 
associated with more rapid progression of the dementia syndrome. . The 
prevalence of delusions in Alzheimer's disease patients ranged from 16% to 
70% (median=36.5%) in the reviewed reports, and the prevalence of 
hallucinations ranged from 4% to 76% (median=23%). Delusions and 
hallucinations tended to persist over time, tended to recur often during the 
course of Alzheimer's disease (Bassiony et al). 
                             Devanand et al, found that the delusions and hallucinations 
in Alzheimer ‘s disease flutuate with time but their over all prevalence 
increases slowly with dementia progression.  Psychotic symptoms occur 
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commonly in Alzheimer's disease (AD), predict a more rapid rate of cognitive 
decline and increase the risk of aggressive behaviour (Gormley et al). Bassiony 
et al in his study found that hallucinations were associated with less education, 
African-American race, more severe dementia, longer duration of illness, falls 
and use of anxiolytics. Delusions were associated with older age, depression, 
aggression, poor general health and use of antihypertensives indicating that 
risk factors varies for different psychotic symptoms. 
                            Delusional patients are more aggressive and exhibit more 
severe activity disturbances than nondelusional patients. Delusional patients 
are more severely cognitively impaired, but the neuropsychological differences 
between the two groups are not outstanding. Delusional patients are more 
behaviorally disturbed than those without delusions (Flynn et al). 
                                     Studies by Dag Aarsland et al ,explored the relationship 
between aggressive behaviour and other neuropsychiatric symptoms in patients 
with Alzheimer’s dementia. There exists a significant, but modest association 
between aggressive behaviour and severity of dementia. One-fourth of variance 
in aggression could be attributed to psychosis. Constantine et al reported that 
aggression is strongly linked with the presence of depressive symptoms and 
concluded that the identification of depression in dementia may be a means of 
preventing and managing physically aggressive behaviour. 
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                 Depression with dementia appeared to lower performance on 
cognitive tests. Following treatment, although cognitive impairment remained 
in the demented range, test performance improved (Greenwald et al ). It has 
been suggested that a new diagnosis should exist, depression in Alzheimer's 
disease. In this diagnosis symptoms of irritability and social isolation or 
withdrawal would be included.  An efficient strategy to diagnose depression in 
dementia amongst elderly patients is to administer the Single Question 
followed by, when necessary, the Cornell scale (Lam et al). High levels of 
depressive symptoms, when persistent in elderly are associated with cognitive 
decline (Sabrina et al). 
 
                            2-year persistence of BPSD in AD was frequently observed 
in patients with agitation and with depressiveness, with less frequency in 
patients with anxiety and aggressiveness, but not in patients with delusions or 
hallucinations. 2-year persistent aggressiveness was associated with older age 
and more functional impairment. More functional impairment was also related 
to 2-year non-persistent hallucinations. Counseling AD patients and their 
families and tailoring therapeutic strategies should take into account the 
different modi of BPSD in AD occurring and persisting longitudinally and 
interacting with functional disturbances (Haupt et al). 
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                                   Currently, there is little that can be done to treat the 
cognitive components of AD. Consequently, our most successful and 
beneficial interventions may focus on the remediable behavioral manifestations 
of the disease. The most valuable treatment approach for patients with AD and 
their caregivers interweaves medications, psychosocial services, environmental 
strategies, and caregiver education.  
 
                                       Although Alzheimer's disease has long been 
considered mainly a cognitive disorder, behavioral and psychological 
symptoms are present from its onset and at all the stages of the disease in most 
patients. They must be identified from the beginning because they orient the 
diagnosis. They include affective and emotional disorders, delusions and 
hallucinations, disorders of instinctual behavior and behavioral problems. The 
best tool for assessing them is the Neuropsychiatric Inventory (NPI). They are 
generally related to neurobiological aspects of the disease but may, especially 
when acute, have multiple etiologies: somatic, iatrogenic, psychological and 
environmental. They condition the course of the disease. As a source of 
suffering and reduced quality of the life and as the primary cause of distress for 
the caregivers and hence of hospitalization and institutionalization, they 
increase the costs of care. The challenge today is to learn more about them and 
thus improves their treatment and especially their prevention. 
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AIM OF THE STUDY 
 
 
 
1. To assess the following behavioural and psychiatric problems 
in patients with Alzheimer ‘s disease 
• Delusions 
• Hallucinations 
• Agitation 
• Dysphoria 
• Anxiety 
• Apathy 
• Elation 
• Disinhibition 
• Irritability 
• Aberrant motor behaviour. 
2. To determine the pattern of behavioural symptoms across the 
three stages of illness in patients with Alzheimer ‘s disease. 
3. To analyse the association between the various behavioural 
domains in patients with Alzheimer ‘s disease. 
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HYPOTHESIS OF THE STUDY 
 
1. There is no significant relationship between advancing age and extent of 
cognitive decline in Alzheimer’s disease. 
2. There exists no difference in the severity of cognitive decline between 
males and females with Alzheimer’s disease. 
3. Low educational status in Alzheimer’s disease is not associated with 
worsening of cognitive decline. 
4. There is no significant relationship between duration of illness and 
cognitive decline in Alzheimer’s disease. 
5. There exists no difference in the pattern of behavioural manifestations in 
the three stages of Alzheimer’s disease. 
6. The frequency of occurrence of behavioural problems does not decrease 
with increase in severity of illness in Alzheimer’s disease. 
7. There is no significant correlation between behavioural problems and 
worsening cognitive function in patients with Alzheimer’s disease. 
8. There is no significant correlation among the 10 behavioural domains 
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MATERIALS AND METHODS 
 
 
STUDY DESIGN- Cross sectional study                 
 
 
SETTING 
 
 
                   The study was conducted at the Outpatient department of 
Institute Of Mental Health, Chennai –10 and Outpatient department, 
Department Of Psychiatry, Government General Hospital, Chennai. The 
study was conducted from August 2005-August 2006. 
 
SAMPLE 
               
                 
                 50 elderly patients suffering from Alzheimer ` s dementia 
(cases) along with their caregivers were recruited from Outpatient 
department, Institute Of Mental Health and Government General Hospital, 
Chennai. 
 
INCLUSION CRITERIA 
 
 
1.  Diagnosis satisfying ICD 10 criteria for Alzheimer’s dementia . 
 
 
2. Duration of illness for a minimum period of 6 months 
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3.  Age group above 65 years 
 
 
EXCLUSION CRITERIA 
 
 
1.  Patients with delirium 
 
2.  H/O psychiatric disorder preceding the onset of memory loss 
 
 
3. H/O head injury with loss of consciousness 
 
 
4. H/O alcohol & other substance abuse 
 
 
5. H/O systemic diseases like hypertension & diabetes. 
 
 
INSTRUMENTS 
 
 
1. Socio demographic data- semi structured interview 
 
 
2. Clinical Dementia Rating Scale (CDRS) 
 
 
3. Neuropsychiatric Inventory (NPI) 
 
 
CLINICAL DEMENTIA RATING SCALE 
 
 
                                   The clinical dementia rating scale was created by 
Hughes and colleagues at Washington University during the early 1980 s 
and has now become the gold standards in global staging of Alzheimer’ s 
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disease. It can be used to assess patients with a broad range of dementia, 
from ‘no impairment’ to ‘ severely impaired’. 
 
                                 It was originally assessed in 58 healthy control 
subjects and 59 people in a community setting suffering from probable or 
mild dementia. Each patient was assessed using the Initial Subject 
Protocol (IPS), a semi structured interview, incorporating the BDRS and 
the Short Portable Mental Status Questionnaire (SPMSQ). Collateral 
history was also collected from an informant. This information was then 
collated to give final scores. 
                                                           
                                   A clinician who knows the patient well usually 
carries out the CDR.the CDR scale includes six domains. 
 The primary domain assessed is Memory.  
 The five secondary domains are  
1. Orientation 
2. Judgement and problem solving 
3.  Community affairs 
4.  Home and hobbies  
5. Personal care. 
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Scoring in CDR scale. 
                             The global CDR score is derived from the scores in 
each of the six domains. Scoring of primary domain, memory (M) is 
first carried out. If atleast three secondary domains have the same 
score as the primary domain the CDR score is equal to the score of the 
primary domain (M). Whenever three or more secondary domains are 
given a score greater or less than the primary domain score (M) the 
majority of scores of the secondary domains that are on whichever side 
of the primary domain, is taken as the CDR score. If there are ties in 
the scores of the secondary domains, the CDR score closest to M is 
chosen. 
 
                         A modified likert scale is used to rate each domain. 
• 0 - healthy people 
• 0.5 -questionable dementia 
• 1- mild dementia 
• 2- moderate dementia 
• 3- severe dementia 
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                               Hughes et al also assessed the validity and reliability 
of the CDR, and found an inter- rater reliability of 0.89(excellent). The 
reliability has been further supported by Burke et al .The CDR is also 
acknowledged to have excellent face validity. Furthermore, the results of 
multicentre trials have shown the CDR to remain reliable (Morris JC) 
                                                        
                                      As the CDR has been in clinical use for several 
years, it has been modified a number of times. The version used in the 
study is the most recent version given by Morris JC, which explains the 
ratings more accurately. 
 
 
NEUROPSYCHIATRIC INVENTORY 
                                                                 
                                 The Neuropsychiatric inventory (NPI) is a multi 
dimensional instrument that assesses 10 behavioural disturbances in 
people with dementia (Cummings et al ). Published in 1994, it drew on 
scales already developed in the field of dementia (BEHAVE-AD, the 
CSDD and the other scales such as the neurobehavioural rating scale used 
to assess the behavioural disturbances following head injury). 
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                             The ten domains (chosen from appropriate literature and 
from UK and US studies examining behavioural disturbances in patients 
with Alzheimer’ s disease, vascular dementia and fronto temporal 
dementia) are as follows: 
1. Delusions 
2. Hallucinations 
3. Agitation 
4. Dysphoria 
5. Anxiety 
6. Elation 
7. Apathy 
8. Disinhibition 
9. Irritability 
10. Aberrant motor behaviour 
                                                               
                                     Many of the subscales in NPI require comment. 
Many scales used in dementia research do not include alterations in 
personality, such as apathy and irritability. However, recent studies 
suggest that these are the most common behavioural disturbances that 
occur in dementia patients (Petry et al). The NPI includes these items to 
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encompass common behaviours in dementia. Investigation of the 
relationship between apathy and regional cerebral blood flow measured by 
SPECT revealed that changes in prefrontal and anterior temporal 
perfusion are most highly correlated with  
apathy scores (Craig et al). 
 
                                     Aberrant motor behaviour refers to the 
spontaneous activities engaged in by many dementia patients. Included are 
the purposeless activities common in AD patients such as pacing and 
rummaging (Reisberg et al). The NPI helps to distinguish among different 
dementias and includes symptoms known to be rare in AD, but common 
in other types of dementia. Euphoria and disinhibition are uncommon in 
AD, but are features of fronto temporal dementia (Miller et al). These two 
features are included in NPI to increase its differential diagnostic utility. 
    
                                 One goal of NPI is to establish characteristic 
neuropsychiatric profiles of different neurological disorders. A variety of 
conditions have been studied, including AD, fronto temporal dementia 
(Levy et al) and progressive supra nuclear palsy (Litvan et al). 
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                                    Whenever possible, terminology used in the sub 
questions was derived from standardised diagnostic criteria such as the 
Diagnostic and Statistical Manual Of Mental Disorders, Fourth edition. 
 
                                         Content validity was rated by an expert Delphi 
panel and was high for the first nine domains; as a result the tenth was 
changed to ‘ Aberrant motor behaviour’. Concurrentvalidity determined 
by correlation with the BEHAVE-AD and the Hamilton Depression 
Rating Scale (HDRS) was good (p.0.01 for nine domains, and p.0.05 for 
one domain). Further analyses showed the NPI to have good inter- rater, 
test-retest and item consistency reliability (Cummings). 
  
                                     In terms of administration, caregivers, who must 
have daily contact with the patient, provide the information to the 
clinician. The caregiver is asked to rate the severity and frequency of each 
of the 10 behavioural domains. 
• Severity (1= mild, 2= moderate, 3= severe)  
• Frequency (1= occasionally= often/once per week, 3= frequently / 
several times per week, 4= very frequently or daily). 
• Composite score is calculated as frequency x severity. 
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METHODOLOGY 
 
  
                                    A group of 50 patients who fulfilled the inclusion 
criteria and exclusion criteria for cases were selected from the Outpatient 
department of Institute Of Mental Health and Government General 
Hospital Psychiatric unit. The caregivers who accompanied the patients 
were also included in the study. All patients were above 65 years of age 
and satisfied the ICD 10 criteria for Alzheimer’s dementia.  
 
                                 Clinical Dementia Rating Scale was administered to 
assess the severity of dementia. Based on CDR scores we identified three 
stages of dementia. 
• Mild dementia (CDR= 1) 
• Moderate dementia (CDR= 2) 
• Severe dementia (CDR= 3) 
                                    
                             The Neuropsychiatric Inventory (NPI) was used to 
assess the behavioural disturbances. The caregivers of all the 50 
patients, who have daily contact with the patient, were administered 
Neuropsychiatric Inventory (NPI) questionnaire. Questions were asked 
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as per NPI protocol. Caregivers were asked to rate the frequency and 
severity of the ten behavioural domains- 
Delusions, Hallucinations, Agitation, Dysphoria, Anxiety, Elation, 
Apathy, Disinhibition, Irritability, Aberrant motor behaviour. 
                       As per NPI scoring frequency of the behavioural domain 
is given a score between 1 to 4 and severity of the behavioural domain 
is given a score between 1 to 3.The score 0 is used when a particular 
behavioural domain is absent. 
                       Composite score is then calculated for each behavioural 
domain. 
    Composite score = frequency score (1 to 4) X severity score (1 to 3) 
      The Composite score lies between 1 and 12. 
                                   Statistical analysis was then carried out to assess the 
pattern of ten behavioural domains in the three groups of patients with 
Alzheimer’s dementia.  
                               The ethics committee and the research panel of the 
Institute Of Mental Health, Chennai after presentation, approved the 
objectives and the methodology of the dissertation. 
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STATISTICAL ANALYSIS 
                                   
                                Statistical analysis was carried out for the 50 subjects 
after categorizing each variable. Base line data of the patients were 
collected from the caregivers. Based on CDR scores we identified three 
stages. Mild dementia (CDR= 1), Moderate dementia (CDR= 2) and 
Severe dementia (CDR= 3). Age, sex, educational status, relationship of 
the caregiver to the patient and the duration of illness were analysed. Chi- 
square test is used to assess the significance of association between the 
age, gender, and duration of illness of the sample in the three stages of 
illness. The number of patients manifesting each of the 10 behavioural 
domains in the three stages of illness is determined. Composite scores for 
each behavioural domain is calculated in all patients. The mean of the 
composite scores for each behavioural domain with in the three stages is 
calculated.  The analysis of variance (ANOVA) is used to compare the 
mean values of the composite scores across the three stages.  Pearson 
Correlation test is used to determine the correlation between the ten 
behavioural domains and to explore the relationship among behaviours.  
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RESULTS 
 
Table 1 
AGE AND GENDER DISTRIBUTION OF THE SAMPLE 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
The age of patients with Alzheimer’s disease ranged from 66 to 76 years. . The 
mean age was 69.6(SD 2.63). Of the total sample of 50 patients, 30were males and 
20 were females  
 
Table 2 
                  
EDUCATIONAL STATUS OF THE SAMPLE POPULATION 
 
  
Educational N (%) 
Status  
None 8(16) 
Minimal 12(24) 
Primary 13(26) 
Secondary 12(24) 
Tertiary 5(10) 
Variable N  (%) 
 66-70 yrs 33 (66) 
Age   
 71-76 yrs 17 (34) 
   
 Male     30 (60) 
Sex   
 Female     20 (40) 
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                                                    8(16%) of them were not educated and 10 (24%) 
had completed tertiary education.12 (24%) patients had minimal education, 
13(26%) with primary education, 12(24%) had completed secondary education. 
 
 
Table 3 
DURATION OF ALZHEIMER’S DEMENTIA IN YEARS 
 
 
 
 
 
 
 
   
 
 
 
                                              The mean duration of illness in the sample population 
was 0.97 years.  20 (40%) of the sample group had 6 months duration of illness, 
19 (38%) had 1 year of illness, 7(14%) had 1.5 years, 3(6%) had 2 years of illness. 
Only one patient in the sample had illness for 3 years. 
                                                           
 
 
 
                                                              
 
Duration (years) N (%) 
   
0.5  20(40) 
1  19(38) 
1.5  7(14) 
2  3(6) 
3  1(2) 
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Table 4 
RELATIONSHIP OF CAREGIVERS TO PATIENTS WITH 
ALZHEIMER’S DEMENTIA 
 
 
 
 
 
 
 
 
 
 
 
 
                                 16(32%) 0f the caregivers were the sons of the total sample, 
while 15(30%) were the spouses, 11(22%) were daughters, 3(6%) were daughters 
– in law and 5 (10%) were others related to the sample group, either their siblings 
or other paid caregivers 
 
 
 
 
 
Caregiver 
relationship N (%) 
  
Spouse 15(30) 
Son 16(32) 
Daughter 11(22) 
Daughter in law 3(6) 
Others 5(10) 
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Table 5 
 
CLINICAL DEMENTIA RATING FOR PATIENTS WITH 
 
ALZHEIMER’S DISEASE 
 
                                                                                                                                                     
 
 
 
 
 
 
 
 
                                            
 
                                       The sample group were classified in to three, based on 
their scores in the Clinical Dementia Rating Scale as mild (CDR 1), moderate 
(CDR 2) and severe (CDR 3). 15 (30%) fall in the mild group, 22(44%) in the 
moderate and 13(26%) in the severe group. 
 
 
CDR STAGE (SCORE) N % 
  
Mild Dementia (CDR 1) 
 
15 
 
30.0 
  
Moderate Dementia 
(CDR2)  
 
22 
 
44.0 
  
Severe Dementia (CDR 3)
 
13 
 
26.0 
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Table 6 
 
COMPARISON OF AGE AND COGNITIVE STATUS OF PATIENTS IN 
THE THREE CDR GROUPS 
 
 
CDR STAGE AGE GROUP (YEARS) CHI-SQUARE 
  66-70 71-76 TEST 
  N (%) N (%)   
      
MILD 11(73.3) 4(26.7)   
    χ2=15.10  
MODERATE 19(86.4) 3(13.6) P=0.001 
    Significant  
SEVERE 3(23.1) 10(76.9)   
      
                 
 
                                    P value of 0.001 signifies that as age advances, the severity 
of the cognitive decline worsens.  
 
Table 7 
 
COMPARISON OF GENDER AND COGNITIVE STATUS OF PATIENTS IN 
THE THREE CDR GROUPS 
 
 
 
CDR STAGE GENDER CHISQUARE 
  MALE FEMALE TEST 
  N(%) N(%)   
      
MILD 7(46.7) 8(53.3)   
    χ2=2.80  
MODERATE 16(72.7) 6(27.3) P=0.24 
    NS  
SEVERE 7(53.8) 6(46.2)   
      
                 NS – Not Significant 
 
 There is no significant relationship between gender and cognitive decline. 
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Table 8 
 
COMPARISON OF DURATION OF ALZHEIMER’S DEMENTIA AND  
 
COGNITIVE STATUS OF PATIENTS IN THE THREE CDR GROUPS 
 
 
CDR STAGE 
DURATION OF ILLNESS 
(YEARS)                        
CHI SQUARE 
TEST  
  0.5 1 1.5 2 3  
  N (%) N (%) N (%) N (%) N (%)  
        
MILD 10(66.7) 3(20) 1(6.7) 1(6.7) 0  
       χ2=15.70 
MODERATE 8(36.4) 9(40.9) 5(22.7) 0 0 P=0.04 
       Significant 
SEVERE 2(15.4) 7(53.8) 1(7.7) 2(15.4) 1(7.7)  
        
 
                               P value of 0.04 signifies that there is strong association 
between duration of Alzheimer’s disease and cognitive decline. 
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                                               Table 9 
 
PERCENTAGE OF ALZHEIMER’S DISEASE PATIENTS WITH BEHAVIOURS 
PRESENT IN THE THREE STAGES OF DEMENTIA SEVERITY AS 
MEASURED BY CDR 
 
 
  
BEHAVIOURAL 
DOMAINS 
MILD 
N (%) 
 
MODERATE 
N (%) 
 
SEVERE               TOTAL 
N (%)                N (%) 
 
DELUSIONS 2(13) 5(23)     4(31)                       11(22) 
HALLUCINATIONS 2(13) 3(14)      1(7)                         6(12) 
AGITATION 7(47) 11(50)     11(85)                     29(58) 
DYSPHORIA 2(13) 10(45)     8(62)                       20(40) 
ANXIETY 4(26) 14(63)     7(54 )                      25(50) 
ELATION 3(20) 0      1(7)                         4(8) 
APATHY 7(47) 17(77)     12(92)                    36(72) 
DISINHIBITION 5(33) 9(40)      4(31)                     18(36) 
IRRITABILITY 5(33) 9(40)     7(54 )                     21 (42) 
ABERRANT 
MOTOR 
BEHAVIOUR 
2(13) 6 (28)     7(54)                     15(30) 
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                                     The most common behaviour was apathy, which was 
exhibited by 72 %of patients, followed by agitation (58%), anxiety (48%), 
irritability (42%), dysphoria and aberrant motor behaviour (both 38%), 
disinhibition (36%), delusions (22%) and hallucinations (10%). 
 
                                                             Table 10 
 
COMPARISON OF MEAN COMPOSITE SCORES OF THE TEN 
BEHAVIOURAL DOMAINS WITH THREE STAGES OF DEMENTIA 
 
CDR P VALUE 
Mild Moderate Severe 
ONE WAY 
ANOVA       
F TEST 
 DOMAINS Mean Mean Mean  
DELUSION 7.33 9.67 9  0.47(NS) 
HALLUCINATION 9 11 12  0.29(NS) 
AGITATION 6.29 7.33 7.27  0.65(NS) 
DYSPHORIA 9 7.5 6.13  0.25(NS) 
ANXIETY 5.17 5.63 6  0.93(NS) 
ELATION 7 . 8  0.67(NS) 
APATHY 8.86 7.53 9.08  0.13(NS) 
DISINHIBITION 6 8 8.25  0.03 significant
IRRITABILITY 
6 8 8  0.03 significant
ABERRANT 
MOTOR 
BEHAVIOR 9 9.17 9.55  0.93(NS) 
 
 
 
 
                                       Disinhibition and irritability were the two 
behavioural problems found to be significantly associated with increasing 
severity of illness, with a p value <0.05. Although apathy, agitation and 
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aberrant motor behaviour were found to be more prevalent in the severe 
stages of illness, no significant results were obtained. 
 
 
Table 11 
 
COMPARISON OF MEAN FREQUENCY, SEVERITY AND COMPOSITE 
NPI SCORES IN MILD (CDR 1), MODERATE (CDR 2) AND SEVERE 
(CDR 3) ALZHEIMER’S DISEASE 
 
 
 
Score 
 
 
 
 
Mild 
 
 
 
Moderate 
 
 
 
Severe 
 
 
 
One way 
ANOVA 
Frequency 
Mean±SD 
 
 
7.6 ± 1.43
 
7.38±2.14
 
8.32±1.7 
 
F=1.09 
P=0.34(NS) 
Severity 
Mean±SD 
 
2.91±0.34
 
2.82±0.51
 
3.21±0.39
F=3.42 
P=0.04(Significant) 
Composite 
Mean±SD 
 
2.30±0.26
 
2.36±0.4 
 
2.53±0.46
F=3.44 
P=0.05(Significant) 
 
 
                             Mean values for the total NPI scores increased across each 
CDR group with a significant difference between the mild and the severely 
impaired groups for the mean severity and the composite scores (p<0.05). 
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Table 12 
2 TAILED PEARSON’S PRODUCT MOMENT CORRELATION OF 
AGITATION WITH OTHER BEHAVIOURAL DOMAINS 
  
Domains  Correlation   r Significance N 
Delusion -0.645 0.117  7 
Hallucination 0.667 0.333  4 
Agitation 1   30 
Dysphoria -0.094 0.797  10 
Anxiety 0.132 0.64  15 
Elation 0.866 0.333  3 
Apathy -0.171 0.460  21 
Disinhibition 0.319 0.403  9 
Irritability -0.316 0.374  10 
Aberrant motor behaviour 0.610 0.007  18 
      
 
                                    Agitation has significant correlation to aberrant motor 
behaviour (r=0.610, p=0.007).  
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Table 13 
 
2 TAILED PEARSON’S PRODUCT MOMENT CORRELATION OF 
DISINHIBITION WITH OTHER BEHAVIOURAL DOMAINS 
 
 
 
Domains  Correlation   r Significance N 
Delusion 0.483 0.187  9 
Hallucination 0.000 1  5 
Agitation -0.319 0.403  9 
Dysphoria -0.359 0.484  6 
Anxiety -0.186 0.606  10 
Elation a .  0 
Apathy 0.045 0.884  13 
Disinhibition 1 .  18 
Irritability 1 0.000  18 
Aberrant motor behaviour -0.158 0.765  6 
      
 
 
                              Disinhibition has positive correlation with irritability(r=1). 
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Table 14 
 
2 TAILED PEARSON’S PRODUCT MOMENT CORRELATION OF  
 
IRRITABILITY WITH OTHER BEHAVIOURAL DOMAINS 
 
 
Domains  Correlation   r Significance N 
Delusion 0.485 0.155  10 
Hallucination 0.000 1  5 
Agitation -0.316 0.374  10 
Dysphoria -0.476 0.233  8 
Anxiety -0.221 0.489  12 
Elation a .  0 
Apathy -0.049 0.858  16 
Disinhibition 1 0.000  18 
Irritability 1 .  21 
Aberrant motor behaviour -0.15 0.749  7 
      
 
 
 
                                  Although irritability has been positively correlated to 
disinhibition, it did not have significant correlation with other behavioural 
domains. 
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Table 15 
 
 
2 TAILED PEARSON’S PRODUCT MOMENT CORRELATION OF  
 
ABERRANT MOTOR BEHAVIOUR WITH OTHER BEHAVIOURAL  
 
DOMAINS 
 
 
 
Domains  Correlation   r Significance N 
Delusion -0.500 0.667  4 
Hallucination 0.866 0.333  2 
Agitation 0.610 0.007  18 
Dysphoria 0.190 0.598  10 
Anxiety 0.042 0.897  12 
Elation 1 0.000  2 
Apathy 0.049 0.858  16 
Disinhibition -0.158 0.765  6 
Irritability -0.150 0.749  7 
Aberrant motor behaviour 1 .  19 
      
 
 
Aberrant motor behaviour has significant positive correlation with elation 
 
(r=1) and agitation(r=0.610). 
 
 
 
 
  45 
 
 
DISCUSSION 
 
                                      
                                   The mean age of onset of Alzheimer ‘s disease in 
our study is 69.6 years (Table 1). This is supported by the study done by 
Antonio et al, in which the mean age of onset was 67 years. The male to 
female ratio in our study is 1.5: 1(Table 1). This varies from the other 
studies conducted by Judith et al in which the females outnumbered 
males. James et al, also found in his study that the male to female ratio 
was 1:2.   
                                             We find from Table 2 that only 10 % of the 
study group had completed tertiary education.40% of the patients with 
Alzheimer ‘s disease had no or only minimal education, which could 
indicate a increased prevalence of Alzheimer ‘s disease in patients with 
low education. Several studies have confirmed age and limited 
education as established risk factors for Alzheimer ‘s disease. Hall et al 
in his study in patients with Alzheimer ‘s disease in the African 
Americans found that low education is important risk factor in the 
causation of Alzheimer ‘s disease. 
                       The mean duration of illness in patients with Alzheimer ‘s 
disease in our study is 0.97 years. It is evident from Table 3 that more 
than 40% of with Alzheimer ‘s disease are brought for treatment with in 
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0.5 to one year of onset of illness. Only one patient in the study had the 
illness for 3 years. This explains us that the caregivers are very sensitive 
to the behavioural changes observed in patients with Alzheimer ‘s 
disease. From Table 4, it is found that the offsprings and the spouse 
were the major caregivers accounting for 62%. Only one patient had a 
paid caregiver. 
 
                               Of the 50 patients with Alzheimer ‘s disease, 
15(30%) belonged to the mild stage of illness.22 (44%) were in the 
moderate group and 13(26%) in the severe group as rated by the 
Clinical Dementia Rating Scale (Table 5). This study tried to assess the 
significance of association between the age and the severity of cognitive 
decline. Table 6 shows that there exists significant association between 
advancing age and the decline in the cognitive status (P=0.001). 
Antonio et al, in his study has suggested advancing age as the most 
important risk factor for Alzheimer ‘s disease. This has been further 
supported by study by James et al. The age distribution of the patients 
with Alzheimer’s dementia in the three stages of illness is shown in 
figure1.   
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                                Similar attempts to find the association between 
gender and the cognitive status were made.  However, no significant 
association was found between female gender and declining cognitive 
status (Table 7). The gender distribution across the three stages of 
Alzheimer ‘s disease is shown in figure 2.Although females are affected 
more with Alzheimer ‘s disease in older age group, in this study, males 
outnumbered females. This could be explained by the limited sample 
size. 
                            Table 8 compares the duration of Alzheimer’s dementia 
and the cognitive status as assessed by the CDR scale. Pvalue of 0.04 
signifies that there exists an association between  increase in the 
duration of Alzheimer’s dementia and severe cognitive decline. Figure 3 
shows the duration of Alzheimer’s dementia in patients in the three 
stages of illness. 
 
                           The most common behavioural manifestation observed 
in the study group is apathy (72%), which is shown in Table 9 Findings 
from the Cache county study on memory in aging by Constantine et al 
showed that apathy was one of the most common mental and 
behavioural disturbances in participants with dementia 
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                              Irritability, a common behaviour in Alzheimer’s 
disease, was present in less than one- half of the patients in this study 
(42%, Table 9). Irritability is distinct from agitation, being defined as 
rapid emotional fluctuations between frustration and impatience with 
the patient becoming easily disturbed.  . In the study conducted by Mega 
and colleagues  in patients with probable dementia, irritability was 
reported to be one of the most common troublesome behaviour. 
 
                       Agitation is broadly defined as non-compliance, refusal to 
co-operate with the caregiver, obstinence, resistance, crying, kicking 
and hard to handle in the Neuro psychiatric inventory. There was steady 
increase in agitation from 50 % to 85% of patients with worsening 
Clinical Dementia Rating scores (Table 9). Aberrant motor behaviour 
such as pacing, picking at clothing are scored separately in the Neuro 
psychiatric inventory, which also increases in patients with severe CDR 
stage. Cynthia et al, have suggested that agitation and depression were 
among the important predictors of institutionalization Because agitation, 
aberrant motor behaviour and irritability are major challenges in the 
care of demented patients, monitoring their individual response to 
treatment is important. 
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               From Table 9,it is seen that dysphoria increased from more 
than 10% in the mild group to more than 60% in the severe group. This 
finding is consistent with the earlier observation by Mega and 
colleagues  .The dysphoria domain of the Neuropsychiatric inventory 
excludes features common to both dementia and depression (eg, 
vegetative symptoms) and reflects the patient ‘s mood state more 
specifically than the commonly used rating scales for depression. 
Anhedonia, a core symptom of depression shares some features with 
apathy.  
                      
                                 Delusions and hallucinations did not always occur 
together across the three groups. Although delusions increased in 
frequency, hallucinations declined in the more severely impaired 
group(Table 9). The independence of these symptoms may point to 
differing underlying pathophysiologic processes. . In one study, these 
phenomena were present around the time of diagnosis, perhaps even 
prompting referral for diagnosis, in 45% of patients. Other studies 
reported that hallucinations, more often visual than auditory, rarely 
manifest early in the illness but may be more common in severe 
dementia (Levy et al).                            
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                                    The earlier literature tended to group the study of 
delusions and hallucinations within the broader category of psychosis, in 
which either of the two would be considered a basis for the presence of a 
psychotic syndrome.  In contrast, it has been proposed that delusions 
and hallucinations differ in their predisposing factors and 
etiopathogenesis. This position now has empirical support. A recent 
population-based study found that patients with Alzheimer's disease can 
be empirically classified into three groups on the basis of their 
neuropsychiatric symptom profile: a group with an affective 
disturbance, a group with a psychotic disturbance, and a group with no 
or other neuropsychiatric disturbances (Ballard et al). The presence of 
hallucinations predicted membership in the second group, whether or 
not delusions were present. In contrast, patients with delusions were 
present in all three groups. On the basis of this work, empirically 
derived criteria for an Alzheimer's disease-associated affective and 
psychotic syndrome have been proposed, with hallucinations being 
critical to the presence of the psychotic syndrome. In addition, Bassiony 
et al. found that delusions and hallucinations had different risk factors 
and consequences and that delusions, but not hallucinations, were 
closely associated with depression. Therefore, delusions and 
hallucinations may best be approached separately, with hallucinations 
  51 
 
 
being most indicative of a psychotic syndrome and delusions being 
indicative of either a psychotic disturbance or an affective disturbance.  
 
                      Table 10 shows that there is significant association 
between certain behavioural problems like disinhibition and irritability 
with worsening cognitive status. This finding differs from the earlier 
study by Mega et al, in which agitation, apathy and aberrant motor 
behaviour were found to be significantly associated with cognitive 
decline. Similar findings were observed in the Cache county study by 
Constantine et al, in which apathy correlated significantly with the 
cognitive decline. 
                                   
                                The mean severity and the composite scores of the 
mild and the severe CDR group vary significantly (P= 0.04 and p=0.05 
respectively) as seen from Table 11. This is consistent with the 
observations done by Mega et al in her study on 50 patients with 
probable dementia. 
 
                                Table 12 shows that agitation has significant 
correlation with the aberrant motor behaviour(r=0.610.p= 0.007).  
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                                  The correlation between disinhibition and 
irritability is shown in Table 13.In our study, there seems to be very 
significant correlation between these two behavioural domains, which 
 is found in other studies too (Constantine et al). An attempt was made 
to assess the relationship between irritability with other domains (Table 
14). Other than disinhibition, irritability did not have significant 
correlation with other behavioural domains.                              
                                                                                   
                                       As seen from Table 15, aberrant motor 
behaviour has positive correlation to elation (r=1) and agitation(r=0.61), 
consistent with earlier studies (Cummings et al) 
 
                                        The positive correlation between these 
behavioural domains as seen from the study emphasizes the importance 
of evaluation of these symptoms with appropriate assessment tools at 
the earliest and manage them with individually tailored interventions 
that includes both pharmacological and non pharmacological measures. 
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SUMMARY 
                     In this Indian based hospital study on Alzheimer’s 
disease, 33% of the study group was in the age group of 66-70 and the 
remaining 17% in the 71-76 groups. The male to female ratio was 1.5: 
1, which is different from the usual observation, where females 
outnumber males. The mean duration of illness was 0.97 years. There is 
significant association between advancing age and cognitive decline. 
Increase in duration of Alzheimer’s disease is associated significantly 
with severe cognitive decline. 
 
                          Among the behavioural domains, 72% of the patients 
had apathy. However, unlike earlier studies, this did not have significant 
correlation to the worsening cognitive status. Similarly, agitation and 
aberrant motor behaviour also did not have significant correlation to the 
cognitive status. The mean composite scores of irritability and 
disinhibition were found to be significantly associated with poor 
cognitive functioning. There was significant difference in the mean 
composite scores of the behavioural problems between the mild and the 
severe CDR groups. Certain behavioural domains had positive 
correlation among them. Aberrant motor behaviour correlated with 
agitation and elation. Disinhibition correlated with irritability 
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CONCLUSION 
 
        From this study, the following conclusions are drawn: 
 
1.  Advancing age and increased duration of illness are significantly 
associated with severe cognitive decline. 
2. Males with Alzheimer’s disease were found to have severe 
cognitive decline than females.  
3. Several behavioural problems occur simultaneously in patients 
with Alzheimer’s disease.  
4. The behavioural problems vary across the various stages of 
Alzheimer’s disease. 
5. Agitation, apathy, dysphoria, disinhibition and aberrant motor 
behaviour become more frequent in the severe stage of 
Alzheimer’s disease. 
6. Disinhibition and irritability have significant correlation to severe 
cognitive impairment. 
7. With in the ten behavioural domains, agitation has significant 
correlation to aberrant motor behaviour and disinhibition has 
significant correlation to irritability. 
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                                      With these results, it is possible to conclude that 
mental and behavioural problems are a central component of 
Alzheimer’s disease, regardless of the stage of illness. Although the 
core feature of dementia is the disturbance in cognition, it seems clear 
that almost all individuals with dementia will exhibit behavioural 
problems at some point of their illness. The severity of the behavioural 
problems increases with the advancement of the illness. 
 
                                          These behavioural problems add substantially 
to the morbidity and the disability of the illness. They are the important 
source of burden to the caregivers. They play an important role in the 
diagnosis and management of Alzheimer’s disease. Early detection and 
treatment of these behavioural problems may reduce the patient 
suffering, caregivers burden and delay hospitalization. 
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LIMITATIONS 
 
1. The main limitation of the study is the lack of longitudinal 
assessment of behavioural changes in Alzheimer’ s disease. 
2. This is a hospital based study and not representative of the 
community. 
3. Various subtypes of dementia have not been analysed in the 
study. 
4. Other behavioural changes like eating disorders, sexual changes, 
vegetative symptoms and diurnal variation of behaviour are not 
assessed in this study. 
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SCOPE FOR FUTURE STUDIES 
 
• Studying the patient longitudinally will allow the characterization 
of the temporal progression of the behavioural disturbances in 
Alzheimer’s disease patients. 
• Applying the Neuropsychiatric inventory to patients with other 
types of dementia such as vascular dementia, fronto temporal 
dementia and dementia in Parkinson’s disease will clarify the 
patterns of behavioural changes related to various 
neuropathologies. 
 
0
10
20
30
40
50
60
70
80
90
100
% OF
 PATIENTS
66-70 YRS 71-76 YRS
AGE IN YEARS
FIGURE 1-AGE DISTRIBUTION OF THE PATIENTS WITH 
ALZHEIMER'S DISEASE
MILD
MODERATE
SEVERE
 
 
0
20
40
60
80
100
% OF
 PATIENTS
MILD MOD SEV
CDR STAGES OF ALZHEIMER'S DISEASE
FIGURE 2- GENDER DISTRIBUTION OF PATIENTS WITH 
ALZHEIMER'S DISEASE
MALE
FEMALE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
% OF 
PATIENTS
MILD MOD SEV
CDR STAGE
FIGURE 3- DURATION OF ALZHEIMER'S DISEASE IN 
THE THREE CDR GROUPS
0.5 YRS
1 YR
1.5 YRS
2 YRS
3 YRS
 
 
 
 
 
 
FIGURE 4- MEAN COMPOSITE SCORES OF TEN BEHAVIOURAL 
DOMAINS ACROSS THE THREE STAGES OF ILLNESS 
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APPENDICES 
 
 
PROFORMA 
 
 
 
 
CASES: 
 
 
1. NAME 
 
 
2.AGE 
 
 
3.SEX                                           1.FEMALE 
                                                      2. MALE 
 
 
4.EDUCATION                          1.NONE 
                                                      2.MINIMAL 
                                                      3.COMPLETED PRIMARY 
                                                      4.COMPLETED SECONDARY (MATRIC) 
                                                       5. COMPLETED TERTIARY (COLLEGE) 
 
 
5. RELATIONSHIP OF THE CAREGIVER 
                                                      1.SPOUSE 
                                                      2.SON/DAUGHTER 
                                               3. SON IN LAW/DAUGHTER IN LAW 
                                               4.SIBLING 
                                               5.OTHERS 
          
  
  
6.DURATION OF ILLNESS
CAREGIVERS 
 
 
 
 
 
1. NAME 
  
 
2.    AGE 
 
 
3.     SEX 
 
 
4.     ADDRESS 
 
 
5.     EDUCATION 
 
 
6.     OCCUPATION 
 
 
7.     INCOME 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CLINICAL DEMENTIA RATING SCALE 
 
Category   healthy      questionable dementia   mild dementia   moderate dementia   severe dementia 
                  CDR 0              CDR 0.5                      CDR 1                  CDR 2                        CDR 3 
 
 
Memory   No memory      Mild consistent           Moderate memory    severe memory         severe memory 
                 Loss                forgetfulness; partial     loss, more marked     loss; only highly      loss; only  
                                       Recollection of events   for recent events;        learned material       fragments  
                                                                              defect interferes          retained; new           remain 
                                                                              with daily activities    material rapidly 
                                                                                                                  lost 
 
 
 
Orientation  fully            fully oriented              some difficulty with      usually disoriented    orientation to 
                     Oriented                                          time relationships;          in time; often to         person only 
                                                                             Oriented for place           place 
                                                                             & person at 
                                                                             examination, but may 
                                                                             have geographic 
                                                                             disorientation 
 
 
 
Judgment     solves           only doubtful              moderate difficulty in       severely impaired    unable to  
& problem  every day      impairment in             handling complex             in handling               make  
solving         problems      solving problems,        problems, social                problems;                 judgements 
                     well              similarities,                  judgement usually            similarities,              or solve 
                                         differences                   maintained                        differences;              problems 
                                                                                                                        social judgement 
                                                                                                                        usually impaired 
 
 
Community independent    only doubtful           unable to function              no pretence of         no pretence  
affairs          function at      or mild                    independently at                 independent            of 
                      usual level      impairment, if         these activities                    function outside     independent 
                      in job,             any, in these           though may still be            home                      function  
                      shopping,        activities                 engaged in some;may                                       outside home 
                      business&                                       still appear normal to 
                      financial                                          casual inspection 
                      affairs,  
                      volunteer & 
                      social groups 
 
 
 
Home            life at home        life at home            mild, but definite            only simple            no significant 
&Hobbies     hobbies,              hobbies,                 impairment of                  chores                   function in  
                     intellectual          intellectual             function at home;            preserved;             home outside 
                     interests well      interests well           more difficult                 very restricted       of own room 
                     maintained          maintained or          chores abandoned;         interests, poorly 
                                                 slightly impaired     more complicated          sustained 
                                                                                  hobbies & interests 
                                                                                  abandoned 
  
Personal      fully                     fully capable            needs occasional           requires                requires much 
Care            capable of             self care                   prompting                     assistance in         help with  
                     self care                                                                                      dressing,              personal care, 
                                                                                                                        hygiene,               often  
                                                                                                                        keeping of            incontinent 
                                                                                                                         personal  
                                                                                                                         effects 
 
SCORING BOX FOR CDR SCALE 
Score 0 0.5 1 2 3 
Memory      
Orientation      
Judgement & Problem 
solving 
     
Community affairs      
Home &Hobbies      
Personal care      
 
 
 
 
 
 
 
NEUROPSYCHIATRIC INVENTORY  
 
A.  DELUSIONS: Y   N   N/A                                                             B. HALLUCINATIONS:  Y N  N/A 
      Frequency           severity                                                                   Frequency               severity              
1. Fear of harm                                                                                 1.     Hears voices                                                                
2. Fear of theft                                                                                  2.     Talks to people not there 
3. Spousal affair                                                                               3.     Sees things not there 
4. Phantom boarder                                                                          4.     Smells things not there      
5. Spouse impostor                                                                           5.     Feels things not there      
6. House not home                                                                           6.    Unusual taste sensations 
7. Fear of abandonment                                                                    7.    Other 
8. Talks to TV, etc. 
9. Other 
 
C.  AGITATION/AGGRESSION:  Y N N/A                              D.  DEPRESSION: Y N N/A 
      Frequency           severity                                                             Frequency               severity              
1. Upset with care giver                                                              1.  Tearful and sobbing                                                             
2. Stubbornness                                                                           2.  States, acts as if sad 
3. Uncooperative; resists help                                                     3.  Puts self down, feels like failure 
4. Hard to handle                                                                         4.  Bad person, deserves punishment 
5. Cursing or shouting angrily                                                     5.  Discouraged, no future 
6. Slams doors; kicks, throws things                                           6.  Burden to family 
7. Hits, harms others                                                                    7.  Talks about dying, killing self 
8. Other                                                                                        8.  Other 
 
 
  
E. ANXIETY:    Y N N/A                                                              F. ELATION/EUPHORIA: Y N N/A 
     Frequency           severity                                                             Frequency               severity              
 
1. Worries about planned events                                                1.  Feels too good, too happy 
2. Feels shaky, tense                                                                   2.  Abnormal humor 
3. Sobs, sighs, gasps                                                                   3.  Childish, laughs inappropriately 
4. Racing heart                                                                           4.  Jokes &remarks not funny to others 
5. Phobic avoidance                                                                   5.  Childish pranks 
6. Separation anxiety                                                                  6.  Talks big, grandiose 
7. Other                                                                                       7.  Other 
   
 
G.  APATHY/INDIFFERENCE: Y N N/A                                    H.  DISINHIBITION:  Y N N/A 
      Frequency           severity                                                                 Frequency               severity              
1. Less spontaneous or active                                                    1.  Acts impulsively 
2. Less likely to initiate conversation                                        2.  Excessively familiar with strangers 
3. Less affectionate, lacking emotions                                      3.  Insensitive or hurtful remarks 
4. Contributes less to household chores                                    4.  Crude or sexual remarks 
5. Less interested in others                                                        5.  Talks openly of private matters 
6. Lost interest in friends or family                                           6.  Inappropriate touching of others 
7. Less enthusiastic about interests                                            7.  Other 
        8.      Other 
 
 
  
 
I.  IRRITABILITY:Y N N/A                                                        J.ABERRANT MOTOR BEHAVIOUR 
                                                                                             Y N N/A 
  Frequency           severity                                                             Frequency               severity              
 
1. Bad temper                                                                             1.  Paces without purpose 
2. Rapid changes in mood                                                          2.  Opens or unpacks closets or                                                 
                                                                                                             Drawers 
       3.     Sudden flashes of anger                                                        3.  Repeatedly dresses &undresses 
       4.     Impatient, trouble coping with delays                                  4.  Repetitive activities or habits 
       5.     Cranky, irritable                                                                     5.  Handling, picking behavior 
       6.     Argues, difficult to get along with                                        6.  Excessive fidgety 
 
       7.     Other                                                                                      7.  Other 
 
 
 
 
 
 
 
 
 
 
 
 
NEUROPSYCHIATRIC INVENTORY SCORING SUMMARY 
 
 
DOMAIN 
 
ABSENT 
 
FREQUENCY 
 
SEVERITY 
FREQUENCY X 
SEVERITY 
DELUSIONS       1  2  3  4       1  2  3  
HALLUCINATIONS    1  2  3  4 1  2  3  
AGITATION  1  2  3  4 1  2  3     
DYSPHORIA  1  2  3  4 1  2  3  
ANXIETY  1  2  3  4 1  2  3  
ELATION  1  2  3  4 1  2  3  
APATHY  1  2  3  4 1  2  3  
DISINHIBITION       1  2  3  4 1  2  3  
IRRITABILITY  1  2  3  4 1  2  3  
ABERRANT 
MOTOR 
BEHAVIOUR 
 1  2  3  4 1  2  3  
TOTAL SCORE     
 
 
 
 
 
 
 
NEUROPSYCHIATRIC INVENTORY RATING SHEET FOR INFORMANT 
 
FREQUENCY: 
1. Occasionally-less than once per week 
2. Often-about once per week 
3. Frequently- several times per week, but less than every day 
4. Very frequently-daily or essentially continuously present 
 
SEVERITY: 
1. Mild- produces little distress 
2. Moderate-more disturbing to the patient, but can be re directed by the caregiver 
3. Severe- very disturbing to the patient and difficult to re direct 
                          
                     The score for each domain is: frequency x severity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
